Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Seminars in Thrombosis and Hemostasis|July 25, 2006
Composition, quality control, and labeling of plasma-derived products for the treatment of von Willebrand diseaseClaudine MazurierCurrent Hematology Reports|September 1, 2005
Type 2N von Willebrand diseaseClaudine Mazurier, Lysiane HilbertInternational Journal of Hematology|February 15, 2002
Molecular genetics of type 2 von Willebrand diseaseEdith Fressinaud, Claudine Mazurier, Dominique MeyerBritish Journal of Haematology|May 25, 2002
Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagentsClaudine Caron, Claudine Mazurier, Jenny GoudemandThrombosis and Haemostasis|September 28, 2002
Standardisation of von Willebrand Factor in therapeutic concentrates: calibration of the 1st International Standard for von Willebrand Factor concentrate (00/514)Anthony R Hubbard, Dawn Sands, Andrew C Chang, et al.Haematologica|September 21, 2004
A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implicationsLysiane Hilbert, Augusto B Federici, Luciano Baronciani, et al.British Journal of Haematology|October 31, 2002
Factor VIII deficiency not induced by FVIII gene mutation in a female first cousin of two brothers with haemophilia AClaudine Mazurier, Armelle Parquet-Gernez, Christine Gaucher, et al.British Journal of Haematology|May 18, 2006
Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand diseaseClaudine Caron, Lysiane Hilbert, Karen Vanhoorelbeke, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 30, 2005
Study of human von Willebrand factor immunogenicity in pigs with severe von Willebrand diseaseAnnick Sauger, Sami Chtourou, Bruno Samor, et al.Thrombosis and Haemostasis|September 6, 2006
Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptideLysiane Hilbert, Paquita Nurden, Claudine Caron, et al.Pageof 3